Femoral vascular closure device use, bivalirudin anticoagulation, and bleeding after primary angioplasty for STEMI: results from the HORIZONS-AMI trial.
about
Comparison of a vascular closure device versus the radial approach to reduce access site complications in non-ST-segment elevation acute coronary syndrome patients: The angio-seal versus the radial approach in acute coronary syndrome trial.Transfemoral approach with systematic use of FemoSeal™ closure device compared to transradial approach in primary angioplasty.Ticagrelor in Triple Antithrombotic Therapy: Predictors of Ischemic and Bleeding Complications.Can femoral access bleeding outcomes be improved?
P2860
Femoral vascular closure device use, bivalirudin anticoagulation, and bleeding after primary angioplasty for STEMI: results from the HORIZONS-AMI trial.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Femoral vascular closure devic ...... s from the HORIZONS-AMI trial.
@en
Femoral vascular closure devic ...... s from the HORIZONS-AMI trial.
@nl
type
label
Femoral vascular closure devic ...... s from the HORIZONS-AMI trial.
@en
Femoral vascular closure devic ...... s from the HORIZONS-AMI trial.
@nl
prefLabel
Femoral vascular closure devic ...... s from the HORIZONS-AMI trial.
@en
Femoral vascular closure devic ...... s from the HORIZONS-AMI trial.
@nl
P2093
P2860
P50
P356
P1476
Femoral vascular closure devic ...... s from the HORIZONS-AMI trial.
@en
P2093
Eugenia Nikolsky
Gregg W Stone
Matthew I Tomey
Philippe Généreux
Ran Kornowski
Sorin J Brener
Thomas C McAndrew
Timothy A Sanborn
P2860
P304
P356
10.1002/CCD.25663
P577
2014-10-28T00:00:00Z